Skip to main content
Erschienen in: Annals of Hematology 9/2020

15.06.2020 | Original Article

Cardiac T2* MR in patients with thalassemia major: a 10-year long-term follow-up

verfasst von: Shahina Daar, Murtadha Al Khabori, Sarah Al Rahbi, Moez Hassan, AbuBakr El Tigani, Dudley J Pennell

Erschienen in: Annals of Hematology | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

The consequence of regular blood transfusion in patients with thalassemia major (TM) is iron overload. Herein, we report the long-term impact of chelation on liver iron concentration (LIC) and cardiac T2* MR in patients with TM. This is a retrospective cohort study over 10 years of adolescents and adults with TM aged at least 10 years who had their first cardiac T2* MR between September 2006 and February 2007. One-year chelation therapy was considered the unit of analysis. A total of 99 patients were included in this study with a median age of 18 years. The median cardiac T2* MR and LIC at baseline were 19 ms and 11.6 mg/g dw, respectively. During follow-up, 18 patients died and six underwent successful bone marrow transplantation. Factors associated with decreased survival were older age (HR 1.12, p = 0.014) and high risk cardiac T2* (HR 8.04, p = 0.004). The median cardiac T2* and LIC significantly improved over the 10-year follow-up period (p = 0.000011 and 0.00072, respectively). In conclusion, this long-term “real-life” study confirms that low cardiac T2* adversely impacts the overall survival in patients with TM. Higher baseline LIC predicts a larger reduction in LIC, and lower baseline cardiac T2* predicts a larger improvement in T2*.
Literatur
1.
Zurück zum Zitat Engle MA, Erlandson M, Smith CH (1964) Late cardiac complications of chronic severe refractory anemia with hemochromatosis. Circulation. 30:698–705PubMedCrossRef Engle MA, Erlandson M, Smith CH (1964) Late cardiac complications of chronic severe refractory anemia with hemochromatosis. Circulation. 30:698–705PubMedCrossRef
2.
Zurück zum Zitat Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B (2000) Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol 110(4):971–977PubMedCrossRef Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B (2000) Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol 110(4):971–977PubMedCrossRef
3.
Zurück zum Zitat Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR et al (2006) Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood. 107(9):3733–3737PubMedCrossRef Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR et al (2006) Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood. 107(9):3733–3737PubMedCrossRef
4.
Zurück zum Zitat Ladis V, Chouliaras G, Berdoukas V, Chatziliami A, Fragodimitri C, Karabatsos F, Youssef J, Kattamis A, Karagiorga-Lagana M (2011) Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population. Eur J Haematol 86(4):332–338PubMedCrossRef Ladis V, Chouliaras G, Berdoukas V, Chatziliami A, Fragodimitri C, Karabatsos F, Youssef J, Kattamis A, Karagiorga-Lagana M (2011) Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population. Eur J Haematol 86(4):332–338PubMedCrossRef
5.
Zurück zum Zitat Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22(23):2171–2179PubMedCrossRef Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22(23):2171–2179PubMedCrossRef
6.
Zurück zum Zitat Mavrogeni SI, Markussis V, Kaklamanis L, Tsiapras D, Paraskevaidis I, Karavolias G, Karagiorga M, Douskou M, Cokkinos DV, Kremastinos DT (2005) A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol 75(3):241–247PubMedCrossRef Mavrogeni SI, Markussis V, Kaklamanis L, Tsiapras D, Paraskevaidis I, Karavolias G, Karagiorga M, Douskou M, Cokkinos DV, Kremastinos DT (2005) A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major. Eur J Haematol 75(3):241–247PubMedCrossRef
7.
Zurück zum Zitat Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J, Wu D, Taylor J, Westwood MA, Anderson LJ, Pennell DJ (2009) Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 120(20):1961–1968PubMedPubMedCentralCrossRef Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J, Wu D, Taylor J, Westwood MA, Anderson LJ, Pennell DJ (2009) Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 120(20):1961–1968PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, Sheppard MN, Porter JB, Walker JM, Wood JC, Galanello R, Forni G, Catani G, Matta G, Fucharoen S, Fleming A, House MJ, Black G, Firmin DN, St. Pierre TG, Pennell DJ (2011) On T2* magnetic resonance and cardiac iron. Circulation. 123(14):1519–1528PubMedPubMedCentralCrossRef Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, Sheppard MN, Porter JB, Walker JM, Wood JC, Galanello R, Forni G, Catani G, Matta G, Fucharoen S, Fleming A, House MJ, Black G, Firmin DN, St. Pierre TG, Pennell DJ (2011) On T2* magnetic resonance and cardiac iron. Circulation. 123(14):1519–1528PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ (2008) Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 10:42PubMedPubMedCentralCrossRef Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ (2008) Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson 10:42PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat St Pierre TG, El-Beshlawy A, Elalfy M, Al Jefri A, Al Zir K, Daar S et al (2014) Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration. Magn Reson Med 71(6):2215–2223PubMedCrossRef St Pierre TG, El-Beshlawy A, Elalfy M, Al Jefri A, Al Zir K, Daar S et al (2014) Multicenter validation of spin-density projection-assisted R2-MRI for the noninvasive measurement of liver iron concentration. Magn Reson Med 71(6):2215–2223PubMedCrossRef
11.
Zurück zum Zitat Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 106(4):1460–1465PubMedPubMedCentralCrossRef Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD (2005) MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 106(4):1460–1465PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Daar S, Pathare AV, Jain R, Zadjali SA, Pennell DJ (2009) T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman. Haematologica. 94(1):140–141PubMedCrossRef Daar S, Pathare AV, Jain R, Zadjali SA, Pennell DJ (2009) T2* cardiovascular magnetic resonance in the management of thalassemia patients in Oman. Haematologica. 94(1):140–141PubMedCrossRef
13.
Zurück zum Zitat Patton N, Brown G, Leung M, Bavishi K, Taylor J, Lloyd J, Lee SH, Tay L, Worthley S (2010) Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion-dependent patients with beta thalassaemia: significant association between low cardiac T2* < 10 ms and cardiac events. Intern Med J 40(6):419–426PubMedCrossRef Patton N, Brown G, Leung M, Bavishi K, Taylor J, Lloyd J, Lee SH, Tay L, Worthley S (2010) Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion-dependent patients with beta thalassaemia: significant association between low cardiac T2* < 10 ms and cardiac events. Intern Med J 40(6):419–426PubMedCrossRef
14.
15.
Zurück zum Zitat El Beshlawy A, El Tagui M, Hamdy M, El Ghamrawy M, Azim KA, Salem D et al (2014) Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients. Ann Hematol 93(3):375–379PubMedCrossRef El Beshlawy A, El Tagui M, Hamdy M, El Ghamrawy M, Azim KA, Salem D et al (2014) Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients. Ann Hematol 93(3):375–379PubMedCrossRef
16.
Zurück zum Zitat Perifanis V, Christoforidis A, Vlachaki E, Tsatra I, Spanos G, Athanassiou-Metaxa M (2007) Comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major. Int J Hematol 86(5):385–389PubMedCrossRef Perifanis V, Christoforidis A, Vlachaki E, Tsatra I, Spanos G, Athanassiou-Metaxa M (2007) Comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major. Int J Hematol 86(5):385–389PubMedCrossRef
17.
Zurück zum Zitat Ambati SR, Randolph RE, Mennitt K, Kleinert DA, Weinsaft JW, Giardina PJ (2013) Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study. Am J Hematol 88(8):652–656PubMedPubMedCentralCrossRef Ambati SR, Randolph RE, Mennitt K, Kleinert DA, Weinsaft JW, Giardina PJ (2013) Longitudinal monitoring of cardiac siderosis using cardiovascular magnetic resonance T2* in patients with thalassemia major on various chelation regimens: a 6-year study. Am J Hematol 88(8):652–656PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Danjou F, Origa R, Anni F, Saba L, Cossa S, Podda G, Galanello R (2013) Longitudinal analysis of heart and liver iron in thalassemia major patients according to chelation treatment. Blood Cells Mol Dis 51(3):142–145PubMedCrossRef Danjou F, Origa R, Anni F, Saba L, Cossa S, Podda G, Galanello R (2013) Longitudinal analysis of heart and liver iron in thalassemia major patients according to chelation treatment. Blood Cells Mol Dis 51(3):142–145PubMedCrossRef
19.
Zurück zum Zitat Pepe A, Meloni A, Rossi G, Midiri M, Missere M, Valeri G et al (2018) Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach. Eur Heart J Cardiovasc Imaging 19(3):299–309PubMedCrossRef Pepe A, Meloni A, Rossi G, Midiri M, Missere M, Valeri G et al (2018) Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach. Eur Heart J Cardiovasc Imaging 19(3):299–309PubMedCrossRef
20.
Zurück zum Zitat Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennell DJ (2003) A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 18(1):33–39PubMedCrossRef Westwood M, Anderson LJ, Firmin DN, Gatehouse PD, Charrier CC, Wonke B, Pennell DJ (2003) A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload. J Magn Reson Imaging 18(1):33–39PubMedCrossRef
21.
Zurück zum Zitat Noetzli LJ, Carson SM, Nord AS, Coates TD, Wood JC (2008) Longitudinal analysis of heart and liver iron in thalassemia major. Blood. 112(7):2973–2978PubMedPubMedCentralCrossRef Noetzli LJ, Carson SM, Nord AS, Coates TD, Wood JC (2008) Longitudinal analysis of heart and liver iron in thalassemia major. Blood. 112(7):2973–2978PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Casale M, Filosa A, Ragozzino A, Amendola G, Roberti D, Tartaglione I et al (2019) Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function. Am J Hematol 94(3):312–318PubMed Casale M, Filosa A, Ragozzino A, Amendola G, Roberti D, Tartaglione I et al (2019) Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function. Am J Hematol 94(3):312–318PubMed
23.
Zurück zum Zitat Au WY, Lam WW, Chu WW, Yuen HL, Ling AS, Li RC et al (2008) A cross-sectional magnetic resonance imaging assessment of organ specific hemosiderosis in 180 thalassemia major patients in Hong Kong. Haematologica. 93(5):784–786PubMedCrossRef Au WY, Lam WW, Chu WW, Yuen HL, Ling AS, Li RC et al (2008) A cross-sectional magnetic resonance imaging assessment of organ specific hemosiderosis in 180 thalassemia major patients in Hong Kong. Haematologica. 93(5):784–786PubMedCrossRef
24.
Zurück zum Zitat Karakas Z, Yilmaz Y, Bayramoglu Z, Karaman S, Aydogdu S, Karagenc AO, Tugcu D, Dursun M (2018) Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience. Radiol Med 123(8):572–576PubMedCrossRef Karakas Z, Yilmaz Y, Bayramoglu Z, Karaman S, Aydogdu S, Karagenc AO, Tugcu D, Dursun M (2018) Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience. Radiol Med 123(8):572–576PubMedCrossRef
25.
Zurück zum Zitat Wahidiyat PA, Iskandar SD, Sekarsari D (2018) Evaluation of iron overload between age groups using magnetic resonance imaging and its correlation with Iron profile in transfusion-dependent thalassemia. Acta Med Indones 50(3):230–236PubMed Wahidiyat PA, Iskandar SD, Sekarsari D (2018) Evaluation of iron overload between age groups using magnetic resonance imaging and its correlation with Iron profile in transfusion-dependent thalassemia. Acta Med Indones 50(3):230–236PubMed
26.
Zurück zum Zitat Daar S, Pathare AV (2006) Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload. Ann Hematol 85(5):315–319PubMedCrossRef Daar S, Pathare AV (2006) Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload. Ann Hematol 85(5):315–319PubMedCrossRef
27.
Zurück zum Zitat Carpenter JP, Roughton M, Pennell DJ (2013) Investigators MIiTM. International survey of T2* cardiovascular magnetic resonance in β-thalassemia major. Haematologica. 98(9):1368–1374PubMedPubMedCentralCrossRef Carpenter JP, Roughton M, Pennell DJ (2013) Investigators MIiTM. International survey of T2* cardiovascular magnetic resonance in β-thalassemia major. Haematologica. 98(9):1368–1374PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC et al (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 89(10):1187–1193PubMed Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC et al (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 89(10):1187–1193PubMed
29.
Zurück zum Zitat Marsella M, Borgna-Pignatti C, Meloni A, Caldarelli V, Dell'Amico MC, Spasiano A, Pitrolo L, Cracolici E, Valeri G, Positano V, Lombardi M, Pepe A (2011) Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study. Haematologica. 96(4):515–520PubMedPubMedCentralCrossRef Marsella M, Borgna-Pignatti C, Meloni A, Caldarelli V, Dell'Amico MC, Spasiano A, Pitrolo L, Cracolici E, Valeri G, Positano V, Lombardi M, Pepe A (2011) Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study. Haematologica. 96(4):515–520PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Pepe A, Gamberini MR, Missere M, Pistoia L, Mangione M, Cuccia L et al (2018) Gender differences in the development of cardiac complications: a multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac follow-up. Br J Haematol 180(6):879–888PubMedCrossRef Pepe A, Gamberini MR, Missere M, Pistoia L, Mangione M, Cuccia L et al (2018) Gender differences in the development of cardiac complications: a multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac follow-up. Br J Haematol 180(6):879–888PubMedCrossRef
31.
Zurück zum Zitat Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R (2006) Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood. 107(9):3738–3744PubMedCrossRef Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R (2006) Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood. 107(9):3738–3744PubMedCrossRef
32.
Zurück zum Zitat Pennell DJ, Udelson JE, Arai AE, Bozkurt B, Cohen AR, Galanello R, Hoffman TM, Kiernan MS, Lerakis S, Piga A, Porter JB, Walker JM, Wood J, American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology and Council on Cardiovascular Radiology and Imaging (2013) Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. Circulation. 128(3):281–308PubMedCrossRef Pennell DJ, Udelson JE, Arai AE, Bozkurt B, Cohen AR, Galanello R, Hoffman TM, Kiernan MS, Lerakis S, Piga A, Porter JB, Walker JM, Wood J, American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology and Council on Cardiovascular Radiology and Imaging (2013) Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. Circulation. 128(3):281–308PubMedCrossRef
Metadaten
Titel
Cardiac T2* MR in patients with thalassemia major: a 10-year long-term follow-up
verfasst von
Shahina Daar
Murtadha Al Khabori
Sarah Al Rahbi
Moez Hassan
AbuBakr El Tigani
Dudley J Pennell
Publikationsdatum
15.06.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 9/2020
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-020-04117-z

Weitere Artikel der Ausgabe 9/2020

Annals of Hematology 9/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.